About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Alzheimer's Disease Disease-Modifying Therapies Market Research 2023-2030 | Emerging Trends, Competitive Structure, and Outlook on Strategic Alliances, M&A, and Venture Investment Trends - ResearchAndMarkets.com

The "Disease-Modifying Therapies for Alzheimer's Disease: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimer's disease. It includes global revenue ($ million) for base year data of 2024, estimates for 2025, and CAGR forecasts through 2030.

Currently, the disease-modifying therapies (DMTs) market for Alzheimer's disease (AD) is in its early stage of development, as the first DMT for AD (lecanemab) was granted full approval by the U.S. FDA in July 2023. Several DMTs are in late-stage (phase 2 and above) clinical trials.

If approved, they can expand the AD DMTs market significantly. The publisher estimates market data for 2024 (the base year) and forecasts values for 2025 through 2030. Other than the approved products, the revenue forecast also considers the potential therapeutic candidates expected to enter during the forecast period and their targeted market potential.

The report analyzes the AD DMTs market by target type (anti-amyloid and other emerging targets), drug (Leqembi, Kisunla, and others), molecule type (large and small), and region (Asia-Pacific, North America, Europe, South America, the Middle East, and Africa).

Report Includes

  • Analysis of the current and future global market for disease-modifying therapies for Alzheimer's disease (AD)
  • Analyses of the global market trends, with market revenue data (sales figures) from 2023 to 2025, forecasts for 2026, and projected CAGRs through 2030
  • Estimates of the market's size and revenue prospects for the global market, accompanied by a market share analysis based on target type, drug type, drug molecule type, and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects, and the impacts of macroeconomic variables
  • Discussion of the underlying opportunities and potential in the disease-modifying therapies market
  • Information on products currently available for the diagnosis and treatment of Alzheimer's, as well as the promising new drug candidates and diagnostic imaging agents
  • Review of key marketed products, clinical trials, competitive scenario and R&D activities
  • An analysis of emerging trends and the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Profiles of the Leading Companies

  • Alzheon Inc.
  • Anavex Life Sciences Corp.
  • Annovis Bio Inc.
  • Biogen
  • Biovie Inc.
  • Eisai Co. Ltd.
  • Johnson & Johnson Services Inc.
  • Lilly
  • Novo Nordisk A/S
  • Taurx Pharmaceuticals Ltd.

Key Topics Covered:

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Alzheimer's Disease Overview
  • Alzheimer's Disease Pathophysiology
  • Pharmaceutical Treatment of AD

Chapter 3 Market Dynamics

  • Market Dynamics Snapshot
  • Drivers
  • High Unmet Need in AD Treatment
  • Use of Biomarkers to Accelerate AD DMTs Approvals
  • Challenges
  • High Failure Rate in AD Drug Development
  • High Cost and Side Effects of Approved DMTs
  • Opportunity
  • DMTs for the Preclinical-Stage of AD

Chapter 4 Regulatory Landscape

  • U.S.
  • Standard Drug Approval Process
  • Expedited Approval Pathways
  • DMTs Approval Status by Country/Region

Chapter 5 Emerging Technologies and Developments

  • A Multi-target Therapeutic Framework
  • Blood Tests for AD Screening and Diagnosis
  • Pipeline Analysis
  • Key Takeaways:
  • Small Molecule DMTs in Phase 3 Clinical Trials
  • Large Molecule DMTs in Phase 3 Clinical Trials

Chapter 6 Market Segment Analysis

  • Segmentation Breakdown
  • Market Analysis, by Target Type
  • Anti-Amyloid
  • Other Emerging Alzheimer's Pathology Targets for DMTs
  • Market Analysis, by Drug
  • Market Analysis, by Drug Molecule Type
  • Large Molecule
  • Small-Molecule
  • Geographic Breakdown
  • Market Analysis by Region
  • North America
  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • South America

Chapter 7 Competitive Intelligence

  • Overview
  • Notable Companies Developing AD DMTs
  • Recent Developments/Strategic Analysis

Chapter 8 Appendix

  • Methodology
  • References
  • Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/k8ljf5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.